199 related articles for article (PubMed ID: 26291566)
1. Considerations for randomizing 1 eye or 2 eyes--reply.
Glassman AR; Melia M
JAMA Ophthalmol; 2015 Oct; 133(10):1221. PubMed ID: 26291566
[No Abstract] [Full Text] [Related]
2. Considerations for randomizing 1 eye or 2 eyes.
Bunce C; Wormald R
JAMA Ophthalmol; 2015 Oct; 133(10):1221. PubMed ID: 26291489
[No Abstract] [Full Text] [Related]
3. Randomizing 1 eye or 2 eyes: a missed opportunity.
Glassman AR; Melia M
JAMA Ophthalmol; 2015 Jan; 133(1):9-10. PubMed ID: 25256889
[No Abstract] [Full Text] [Related]
4. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2017 Mar; 33(2):65. PubMed ID: 28099041
[No Abstract] [Full Text] [Related]
5. Preface.
Vavvas D; Gragoudas ES; Hatton MP
Int Ophthalmol Clin; 2004; 44(3):xiii. PubMed ID: 15211188
[No Abstract] [Full Text] [Related]
6. [The use of magnetic fields in ophthalmology].
Skrinnik AV; Moiseeva NN
Oftalmol Zh; 1990; (8):492-6. PubMed ID: 2095478
[No Abstract] [Full Text] [Related]
7. [Kinetics of drugs in ophthalmology].
Lapalus P; Moulin G; Fredj D
Bull Soc Ophtalmol Fr; 1985 Nov; Spec No():31-48. PubMed ID: 2866043
[No Abstract] [Full Text] [Related]
8. Potential use of ocular-insert therapy in dry eyes.
Pavan-Langston D
Int Ophthalmol Clin; 1973; 13(1):231-8. PubMed ID: 4724259
[No Abstract] [Full Text] [Related]
9. Pharmaceutical Emulsions: A Viable Approach for Ocular Drug Delivery.
Bisen AC; Srivastava S; Mishra A; Sanap SN; Biswas A; Choudhury AD; Dubey A; Gupta NM; Yadav KS; Mugale MN; Bhatta RS
J Ocul Pharmacol Ther; 2024 Jun; 40(5):261-280. PubMed ID: 38654153
[No Abstract] [Full Text] [Related]
10. Self-medication in ophthalmology: a questionnaire-based study in an Argentinean population.
Marquez GE; Torres VE; Sanchez VM; Gramajo AL; Zelaya N; Peña FY; Juarez CP; Luna JD
Ophthalmic Epidemiol; 2012 Aug; 19(4):236-41. PubMed ID: 22775280
[TBL] [Abstract][Full Text] [Related]
11. Use of drugs in the eye.
Ellis PP
GP; 1968 Oct; 38(4):99-108. PubMed ID: 5679524
[No Abstract] [Full Text] [Related]
12. Drug delivery to the eye: current trends and future perspectives.
Behar-Cohen F
Ther Deliv; 2012 Oct; 3(10):1135-7. PubMed ID: 23116006
[No Abstract] [Full Text] [Related]
13. [Ocular pharmacology in the treatment of vitreous, retina and choroid diseases].
Filho PA; Maia M; Rodrigues EB; Farah ME
Arq Bras Oftalmol; 2010; 73(3):294-9. PubMed ID: 20730292
[TBL] [Abstract][Full Text] [Related]
14. [Drug therapy in ophthalmology].
Verdy P; Montin JF
Soins Chir; 1983; (28-29):47-50. PubMed ID: 6555883
[No Abstract] [Full Text] [Related]
15. [Homogeneous functional group, value--added tax, eye drops and ocular injections, personal computer and secundum artem].
Recio Blázquez ML
Farm Hosp; 2004; 28(4):291-3. PubMed ID: 15369440
[No Abstract] [Full Text] [Related]
16. [Electrotherapy in ophthalmology. Iontophoresis].
Sobecki R
Klin Oczna; 1988 Feb; 90(2):71-3. PubMed ID: 3411899
[No Abstract] [Full Text] [Related]
17. Ocular application of chitosan.
Başaran E; Yazan Y
Expert Opin Drug Deliv; 2012 Jun; 9(6):701-12. PubMed ID: 22530690
[TBL] [Abstract][Full Text] [Related]
18. Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations.
Shen J; Lu GW; Hughes P
Pharm Res; 2018 Sep; 35(11):217. PubMed ID: 30255364
[TBL] [Abstract][Full Text] [Related]
19. Eyes on new product development: ophthalmic drug delivery.
Novack GD
J Ocul Pharmacol Ther; 2013 Mar; 29(2):90-1. PubMed ID: 23485090
[No Abstract] [Full Text] [Related]
20. [Side effects of drugs in ophthalmology].
Polak BC; Henkes HE
Ned Tijdschr Geneeskd; 1987 Dec; 131(49):2254-7. PubMed ID: 3696257
[No Abstract] [Full Text] [Related]
[Next] [New Search]